Furthermore, FOXA1, GATA3, ESR1 and SPDEF are reported as master regulators in FGFR2 signaling and breast cancer risk in ER+ cells (Fletcher et al., 2013). This evidence concerns the gene FGFR2 and breast carcinoma.